ALLAN C SILBER
CIK 1009161 · Executive Chairman · last filed 2023-12-27
ALLAN C SILBER is an Executive Chairman who has filed 35 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for PNT, was dated Dec 27, 2023. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.57M
3
35
-$2.20M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| POINT Biopharma Global Inc. (PNT) Delisted | Executive Chairman | 4,268,605 | $12.50 | $53.36M | $311.2K | 5 | 2023-12-27 |
| HGBL | 10%+ Owner | 3,598,215 | $1.27 | $4.57M | -$2.51M | 7 | 2021-09-03 |
| POINT Biopharma Global Inc. (RACA) Delisted | Director | 8,254,260 | $10.27 | $84.81M | $0 | 1 | 2021-06-30 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-12-27 | POINT Biopharma Global Inc. (PNT) Delisted | Mixed | −8,727,975 | $0 | EDGAR |
| 2023-11-07 | POINT Biopharma Global Inc. (PNT) Delisted | Gift (G) | −500,000 | $0 | EDGAR |
| 2023-03-30 | POINT Biopharma Global Inc. (PNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-21 | POINT Biopharma Global Inc. (PNT) Delisted | Buy (P) | +50,000 | $311.2K | EDGAR |
| 2022-03-31 | POINT Biopharma Global Inc. (PNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-03 | HGBL | Sell (S) | −53,467 | -$115.1K | EDGAR |
| 2021-08-31 | HGBL | Sell (S) | −71,101 | -$151.0K | EDGAR |
| 2021-08-26 | HGBL | Sell (S) | −155,162 | -$298.3K | EDGAR |
| 2021-08-20 | HGBL | Sell (S) | −81,400 | -$145.7K | EDGAR |
| 2021-08-17 | HGBL | Sell (S) | −2,500 | -$4.8K | EDGAR |